Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 5

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 5
---
 rounded up to the nearest whole number. The terms of the Working Capital Warrants, if any, would be identical to the terms of the private placement warrants issued by APx at the time of its initial public offering. On February9, 2024, the Company and Templar Sponsor amended and restated the Working Capital Promissory Note (the “Amended and Restated Note”), to increase the maximum principal amount from $500,000 to $2,000,000. As of March31, 2025, the fair value of these Working Capital Warrants is not significant, according to APx’s estimates. Therefore, any shares issuable under these Warrants were not considered for the purposes of the pro forma information presented herein. This proxy statement/prospectus describes certain redemption rights that may be exercised by APx’s Public Shareholders (as defined below) of their Public Shares. Pursuant to the IPO Letter Agreements (as defined in this proxy statement/prospectus) and as further discussed in the section entitled “ Certain Agreements Related to the Business Combination — Voting and Support Agreement,” the Initial Shareholders and certain APx’s officers and directors have agreed to vote shares representing approximately 89.2% of the aggregate voting power of the ordinary shares in favor of the proposals above. Accordingly, the agreement by the Initial Shareholders and APx’s officers and directors to vote in favor of these proposals will increase the likelihood that APx will receive the requisite shareholder approval for the above proposals, including the Business Combination Proposal. If all Founders Shares are voted in favor of the above proposals, none of the 520,056 Public Shares outstanding need to be voted in favor of the above proposals (assuming all outstanding shares are voted) in order to have such proposals approved.

APx is providing this proxy statement/prospectus and accompanying proxy card to its shareholders in connection with the solicitation of proxies to be voted at the Special Meeting and at any adjournments or postponements thereof. Whether or not you plan to attend the Special Meeting, APx urges you to read this proxy statement/prospectus carefully. Please pay particular attention to the section entitled “ Risk Factors ,” beginning on page 25. SPAC Units (as defined below), Public Shares and Public Warrants are currently listed on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbols “APXIU,” “APXI” and “APXIW,” respectively. Although the Company is not currently a public company, following the Closing, the